Hyderabad-based Indian Immunologicals Limited (IIL) has partnered with Australia’s Griffith University to develop the COVID-19 vaccine. Scientists from IIL and Griffith University will jointly develop a “live attenuated SARS – CoV-2 vaccine” or COVID-19 vaccine using the “latest codon de-optimization technology”.
Click Here To Get Test Series For SBI PO 2020
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization. Upon the completion of the research, the vaccine strain will be transferred to ILL. It will work with the Central Drugs Standard Control Organisation (CDSCO), to conduct clinical trials. IIL intends to use its Vero cell platform tech for mass production of the vaccine.
What is Indian Immunologicals Limited?
Indian Immunologicals Limited is a major player in the human vaccine market in the country, supplying human pediatric and rabies vaccines. IIL is also a major supplier of pediatric vaccines to the country’s state-run universal immunization programme. IIL is promoted by the National Dairy Development Board. It is committed to addressing critical public health needs by engaging in this collaboration.
Important takeaways for all competitive exams:
Countdown for the most exciting sports tournament in the world has officially begun. Fans across…
India delivered the exceptional performance at the Asian Boxing U15 Championships 2026 and finished with…
As President of United States Donald Trump paid visit to China few days ago, both…
Indian Institute of Tropical Meteorology (IITM) Pune has launched a dedicated startup incubation centre which…
Centre has launched the ₹189.79 crore Mizoram Ginger Mission. This initiative aims to transform the…
The state of Rajasthan entered into the India's fastest growing semiconductor and electronics manufacturing sector…